Abstract
Objectives: The worldwide spread of coronavirus disease 2019 (COVID-19) highlights the need for assessment of long-term humoral immunity in convalescent subjects. Our objectives were to evaluate long-term IgG antibody response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and B-cell memory response in COVID-19 convalescent subjects.
Methods: Blood samples were collected from a cohort of subjects recovering from COVID-19 and from healthy subjects who donated blood. SARS-CoV-2 IgG antibodies were quantitatively detected by ELISA using anti-S1 spike IgG. SARS-CoV-2 spike-specific IgG memory B cells were evaluated by reversed B-cell FluroSpot based on human IgG SARS-CoV-2 receptor-binding domain in a randomly selected group of subjects recovering from COVID-19. Statistical analysis was performed with clinical variables and time post COVID-19 infection.
Results: Antibody response was not detected in 26 of 392 COVID-19 convalescent subjects (6.6%). Over a period of 9 months, the level of antibodies decreased by 50% but stabilized at 6 months, and a protective level prevailed for up to 9 months. No differences were found regarding IgG SARS-CoV-2 antibody levels for age, gender, and major blood types over time. Over time, asymptomatic COVID-19 subjects did not differ in antibody level from subjects with mild to severe disease. Repeated paired IgG SARS-CoV-2 antibody level analyses disclosed that, over 6 and 9 months, 15.3% (nine of 59) and 15.8% (three of 19) of subjects became SARS-CoV-2 IgG-seronegative, respectively, all with a low antibody level at 3 months. Rate of antibody decline was not affected by age, gender, or clinical symptomatology. In a subgroup of recovering subjects, memory B-cell response up to 9 months post-COVID-19 infection was undetectable in 31.8% of subjects (14/44), and there was no correlation with age, SARS-CoV-2 antibody level, or time post infection.
Conclusions: The majority of convalescent COVID-19 subjects develop an IgG SARS-CoV-2 antibody response and a protective level prevails over a period of up to 9 months, regardless of age, gender, major blood types or clinical symptomatology.
Keywords: Anti-SARS-CoV-2 IgG; Antibody; COVID-19; Memory B-Cells; Time-related humoral response.
【저자키워드】 COVID-19, antibody, anti-SARS-CoV-2 IgG, Memory B-cells, Time-related humoral response., 【초록키워드】 coronavirus disease, SARS-CoV-2, IgG, coronavirus, Infection, Gender, ELISA, Spread, Humoral immunity, Cohort, IgG antibody, SARS-CoV-2 antibody, COVID-19 infection, SARS-CoV-2 IgG antibody, Mild, age, convalescent, Blood, memory B cell, Protective, spike IgG, B-cell, memory response, Analysis, severe disease, humoral, memory B-cell, acute respiratory syndrome, subject, domain, blood sample, no correlation, post infection, over, Randomly, highlight, selected, not differ, collected, develop, evaluate, Rate, evaluated, nine, was performed, majority, subjects, not affected, healthy subject, reversed, asymptomatic COVID-19 subject, clinical variable, recovering from COVID-19, SARS-CoV-2 spike-specific, undetectable, 【제목키워드】 SARS-CoV-2 antibody, convalescent, B-cell, memory response, subject,